Nuclear expression of survivin portends a poor prognosis in Merkel cell carcinoma

Modern Pathology

Volumn 21, Issue 6, 2008, Pages 764-769

  Kim, Jinah ^a   McNiff, Jennifer M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Merkel cell carcinoma; Prognosis; Survivin

Indexed keywords

SURVIVIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MERKEL CELL TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

AGED; AGED, 80 AND OVER; CARCINOMA, MERKEL CELL; CELL NUCLEUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PROGNOSIS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 44349100960     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2008.61     Document Type: Article

References (34)

1. Merkel F. Tastzellen und Taskörperchen bei den Hausthieren und beim Menschen. Arch Mikr Anat 1875;11:636.
2. Winkelman R, Breathnach A. The merkel cell. J Invest Dermatol 1973;60:2-15.
3. Toker C. Trabecular carcinoma of skin. Arch Dermatol 1972;105:107-110.
4. Miller R, Rabkin C. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev 1999;8:153-158.
5. Lemos B, Nghiem P. Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol 2007;127:2100-2103.
6. Goessling W, McKee P, Mayer R. Merkel cell carcinoma. J Clin Oncol 2002;20:588-598.
7. Coit D. Merkel cell carcinoma. Ann Surg Oncol 2001;9S:99S-102S.
8. McAfee W, Morris C, Mendenhall C, et al. Merkel cell carcinoma: treatment and outcomes. Cancer 2005;104:1761-1764.
9. Smith P, Patterson J. Merkel cell carcinoma (neuroendocrine carcinoma of the skin). Am J Clin Path 2001;115S:S68-S78.
10. Skelton H, Smith K, Hitchcock C, et al. Merkel cell carcinoma: analysis of clinical histologic, and immunohistologic features of 132 cases with relation to survival. J Am Acad Dermatol 1997;37:734-739.
11. Asioli S, Righi A, Volante M, et al. p63 as a new prognostic marker in Merkel cell carcinoma. Cancer 2007;110:640-647.
12. Schlagbauer-Wadl H, Klosner G, Heere-Ress E, et al. Bcl-2 antisense oligonucleotides (G3139) inhibit Merkel cell carcinoma growth in SCID mice. J Invest Dermatol 2000;114:725-730.
13. Ambrosini D, Adida C, Altieri D. A novel antiapoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917-921.
14. Deveraux Q, Reed J. IAP family proteins suppressors of apoptosis. Genes Dev 1999;13:239-252.
15. Adida C, Crotty P, McGrath J, et al. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Path 1998;152:43-49.
16. Kobayashi K, Hatano M, Otaki M, et al. Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation. Proc Natl Acad Sci 1999;96:1457-1462.
17. Grossman D, McNiff J, Li F, et al. Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J Invest Dermatol 1999;113:1076-1081.
18. Monzo M, Rosell R, Felip E, et al. A novel antiapoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol 1999;17:2100-2104.
19. Tanaka K, Iwamoto S, Gon G, et al. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 2000;6:127-134.
20. Lu C, Altieri D, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 1998;58:1808-1812.
21. Satoh K, Kaneko K, Hirota M, et al. Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors. Cancer 2001;92:271-278.
22. Kawasaki H, Altieri D, Lu C, et al. Inhibition of apoptosis by survivin predicts shorter survivial rates in colorectal cancer. Cancer Res 1998;58:5071-5074.
23. Saitoh Y, Yaginuma Y, Ishikawa M. Analysis of Bcl-2, Bax and Survivin genes in uterine cancer. Int J Oncol 1999;15:135-141.
24. Yoshida H, Ishiko O, Sumi T, et al. Survivin, bcl-2 and matrix metalloproteinase-2 enhance progression of clear cell- and serous-type ovarian carcinomas. Int J Oncol 2001;19:537-542.
25. Swana H, Grossman D, Anthony J, et al. Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 1999;341:452-453.
26. Piras F, Murtas D, Minerba L, et al. Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma. Histopathology 2007;50:835-842.
27. Bria E, Visca P, Novelli F, et al. Nuclear and cytoplasmic cellular distribution of survivin as survivial predictor in resected non-small-cell lung cancer. Eur J Surg Oncol 2007; doi:10.1016/j.ejso.2007.06. 002.
28. Altieri D. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003;22:8581.
29. Fortugno P, Wall N, Giodini A, et al. Survivin exists in immunohistochemically distinct subcellular pools and is involved in spindlemicrotubule function. J Cell Sci 2002;115:575-585.
30. Ruchaud S, Carmena M, Earnshaw W. Chromosomal passengers: conducting cell division. Nat Rev Mol Cell Biol 2007;8:798-812.
31. Adams R, Carmena M, Earnshaw W. Chromosomal passengers and the (aurora) ABCs of mitosis. Trends Cell Biol 2001;11:49-54.
32. Wheatley S, Barrett R, Andrews P, et al. Phosphorylation by aurora-B negatively regulates survivin function during mitosis. Cell Cycle 2007;6:1220-1230.
33. O'Connor D, Grossman D, Plescia J, et al. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci 2000;97:13103-13107.
34. Yan H, Thomas J, Lui T, et al. Induction of melanoma and inhibition of tumor growth using a cell-permeable Survivin antagonist. Oncogene 2006;25:6968-6974.